Despite many high-quality randomized trials, the balance ofharm and benefit attributable to breast-cancer screening isnot known for women 40 to 49 years of age. In this issue ofthe Journal, Elmore et al.1 describe a high rate of false positiveresults of such screening. Over a period of 10 years, nearlyone third of the women screened had at least one false positivemammogram or clinical breast examination. Physicians must integratethis information into their approach to helping women decideabout breast-cancer screening.
Periodic screening invites repeated exposure to the possibilityof a false positive result, as occurs . . . [Full Text of this Article]
References
Related Letters:
False Positive Rate of Screening Mammography
Olivotto I. A., Kan L., Coldman A. J., Paci E., Giorgi D., del Turco M. R., Roux S., Markle L., Diamond A., Sickles E. A., Fishbein M., Gross T. L., Kopans D. B., Feig S. A., Elmore J. G., Barton M. B., Arena P. J., Sox H. C.
Extract |
Full Text
N Engl J Med 1998;
339:560-564, Aug 20, 1998.
Correspondence
This article has been cited by other articles:
Kopans, D. B.
(2005). Bias in the Medical Journals: A Commentary. Am. J. Roentgenol.
185: 176-182
[Abstract][Full Text]
Kemper, A. R., Downs, S. M.
(2000). A Cost-effectiveness Analysis of Newborn Hearing Screening Strategies. Arch Pediatr Adolesc Med
154: 484-488
[Abstract][Full Text]
Anderson, R. E.
(1999). Billions for Defense: The Pervasive Nature of Defensive Medicine. Arch Intern Med
159: 2399-2402
[Full Text]
Sargent, J. D., Dalton, M., Klein, R. Z.
(1999). Diagnostic Testing Unwarranted for Children With Blood Lead 10 to 14 µg/dL. Pediatrics
103: 51e-51
[Abstract][Full Text]
Olivotto, I. A., Kan, L., Coldman, A. J., Paci, E., Giorgi, D., del Turco, M. R., Roux, S., Markle, L., Diamond, A., Sickles, E. A., Fishbein, M., Gross, T. L., Kopans, D. B., Feig, S. A., Elmore, J. G., Barton, M. B., Arena, P. J., Sox, H. C.
(1998). False Positive Rate of Screening Mammography. NEJM
339: 560-564
[Full Text]